Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3536
Title: | Liver disease in the older child | Authors: | Ee, L. C. | Issue Date: | 2020 | Source: | 56, (11), 2020, p. 1702-1707 | Pages: | 1702-1707 | Journal: | Journal of Paediatrics and Child Health | Abstract: | Liver disease in children tends to present either as: (i) an acute hepatitis with or without jaundice; (ii) incidental finding of abnormal liver function tests; or (iii) from a complication of portal hypertension with either haematemesis and/or incidental splenomegaly. Acute hepatitis may result from acute infection, prescribed or other drugs, ischaemia or vascular causes, autoimmune hepatitis, or idiopathic liver failure. Non-alcoholic fatty liver disease is now the most likely reason for abnormal liver function tests but medications, metabolic disease, cholangiopathy and non-liver causes should be considered. Autoimmune hepatitis and alpha-1-antitrypsin deficiency are the most likely causes of insidious liver disease. An international normalised ratio uncorrected by vitamin K reflects the severity of liver synthetic dysfunction, but not propensity to bleed. Creatine kinase helps to differentiate muscle from liver disease in patients with raised transaminases. Doppler ultrasound of hepatic vasculature is useful when assessing splenomegaly to differentiate extra-hepatic portal hypertension from inherent liver disease.L20073012372020-11-19 | DOI: | 10.1111/jpc.14708 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2007301237&from=exporthttp://dx.doi.org/10.1111/jpc.14708 | | Keywords: | creatine kinase;cyclosporine;defibrotide;herbaceous agent;kava;metformin;midomafetamine;mycophenolate mofetil;nonsteroid antiinflammatory agent;paracetamol;sinecatechins;steroid;tacrolimus;ursodeoxycholic acid;valproic acid;vancomycin;vitamin K group;acute hepatitis;acute liver failure;alanine aminotransferase blood level;alpha 1 antitrypsin deficiency;aspartate aminotransferase blood level;autoimmune hepatitis;autoimmune liver disease;bariatric surgery;bilirubin blood level;cholangiography;colorectal cancer;cystic fibrosis;differential diagnosis;disease severity;Doppler ultrasonography;drug fatality;drug megadose;drug response;hematemesis;human;hypertransaminasemia;incidental finding;infectious hepatitis;international normalized ratio;jaundice;lifestyle modification;liver circulation;liver disease;liver function test;liver ischemia;liver toxicity;liver venoocclusive disease;morbid obesity;nonalcoholic fatty liver;pathogenesis;portal hypertension;portosystemic anastomosis;prevalence;primary sclerosing cholangitis;priority journal;splenomegaly;toxic hepatitis;Wilson disease;review;Actaea racemosa extractalanine aminotransferase;alpha tocopherol;anticonvulsive agent;antiinfective agent;antineoplastic agent;aspartate aminotransferase;azathioprine;beta adrenergic receptor blocking agent;bilirubin;budesonide;calcineurin inhibitor;cocaine;corticosteroid | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.